East Sussex - Better Together
NHS

Oscillating Positive Expiratory Pressure (PEP) devices

PEP devices have shown benefits in a variety of lung diseases, such as cystic fibrosis, bronchiecstasis, and COPD, where secretion clearance is problematic despite physiotherapy, and are recommended by the British Thoracic Society.

The preferred choice of device is the Acapella device, as it has variable resistance, can be used in any body position, and has an additional vibratory function to aid secretion clearance.
The device is to be used as an adjunctive treatment only after a physiotherapy respiratory assessment, when other secretion clearance techniques are not sufficiently effective.
Patient training videos and booklets to support the patient’s use of the device will be provided by the physiotherapy team.

Acapella provides an alternative to the active cycle of breathing technique, which improves lung function and symptoms, reduces exacerbations, and empowers patients to support self-management.

Potential side effects
Fainting due to increased intrathoracic pressure
Increased bronchospasm
Pneumothorax
Haemoptysis

Patients should be warned and risk assessed.

One device to be prescribed every 6 months

The first device will be supplied by the RESPS team during the initial training and assessment of effectiveness; ongoing prescribing will be via the GP

Pack
1 device
  • First Line Drugs
  • Second Line Drugs
  • Specialist Initiated Drugs
  • Specialist Only Drugs
  • Mixed Status